These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28084586)

  • 1. Amelioration of high fat diet-induced nephropathy by cilostazol and rosuvastatin.
    Park JH; Choi BH; Ku SK; Kim DH; Jung KA; Oh E; Kwak MK
    Arch Pharm Res; 2017 Mar; 40(3):391-402. PubMed ID: 28084586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice.
    Kim DH; Choi BH; Ku SK; Park JH; Oh E; Kwak MK
    PLoS One; 2016; 11(4):e0153965. PubMed ID: 27097221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinational Use of Antiplatelet Medication Sarpogrelate with Therapeutic Drug Rosuvastatin in Treating High-Cholesterol Diet-Induced Chronic Kidney Disease in ApoE-Deficient Mice.
    Xu J; Pei Z; Yu M; Li X; Wang L; Lin Y; Chen X; Liu X
    Biomed Res Int; 2020; 2020():1809326. PubMed ID: 33029491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
    Giunti S; Calkin AC; Forbes JM; Allen TJ; Thomas MC; Cooper ME; Jandeleit-Dahm KA
    Am J Physiol Renal Physiol; 2010 Sep; 299(3):F528-35. PubMed ID: 20554645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hydrophilic statins on renal tubular lipid accumulation in diet-induced obese mice.
    Gotoh K; Masaki T; Chiba S; Ando H; Fujiwara K; Shimasaki T; Tawara Y; Toyooka I; Shiraishi K; Mitsutomi K; Anai M; Itateyama E; Hiraoka J; Aoki K; Fukunaga N; Nawata T; Kakuma T
    Obes Res Clin Pract; 2013; 7(5):e342-52. PubMed ID: 24455762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
    Okada Y; Yamaguchi K; Nakajima T; Nishikawa T; Jo M; Mitsumoto Y; Kimura H; Nishimura T; Tochiki N; Yasui K; Mitsuyoshi H; Minami M; Kagawa K; Okanoue T; Itoh Y
    Liver Int; 2013 Feb; 33(2):301-11. PubMed ID: 23295058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial anti-inflammatory effects of combined rosuvastatin and cilostazol in a TNF-driven inflammatory model.
    Cho O; Jang YJ; Park KY; Heo TH
    Pharmacol Rep; 2019 Apr; 71(2):266-271. PubMed ID: 30822620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin is additive to high-dose candesartan in slowing progression of experimental mesangioproliferative glomerulosclerosis.
    Krämer S; Kron S; Wang-Rosenke Y; Loof T; Khadzhynov D; Morgera S; Kawachi H; Shimizu F; Martini S; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2008 Apr; 294(4):F801-11. PubMed ID: 18216152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet.
    de las Heras N; Valero-Muñoz M; Ballesteros S; Gómez-Hernández A; Martín-Fernández B; Blanco-Rivero J; Cachofeiro V; Benito M; Balfagón G; Lahera V
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1107-14. PubMed ID: 23434394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silymarin protects against renal injury through normalization of lipid metabolism and mitochondrial biogenesis in high fat-fed mice.
    Bin Feng ; Meng R; Bin Huang ; Bi Y; Shen S; Zhu D
    Free Radic Biol Med; 2017 Sep; 110():240-249. PubMed ID: 28625483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol attenuates murine hepatic ischemia and reperfusion injury via heme oxygenase-dependent activation of mitochondrial biogenesis.
    Joe Y; Zheng M; Kim HJ; Uddin MJ; Kim SK; Chen Y; Park J; Cho GJ; Ryter SW; Chung HT
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G21-9. PubMed ID: 25951827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin.
    Wu D; Wen W; Qi CL; Zhao RX; Lü JH; Zhong CY; Chen YY
    Phytomedicine; 2012 Jun; 19(8-9):712-8. PubMed ID: 22483555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin suppresses atrial tachycardia-induced cellular remodeling via Akt/Nrf2/heme oxygenase-1 pathway.
    Yeh YH; Kuo CT; Chang GJ; Chen YH; Lai YJ; Cheng ML; Chen WJ
    J Mol Cell Cardiol; 2015 May; 82():84-92. PubMed ID: 25771143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
    Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
    Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane protein 126B protects against high fat diet (HFD)-induced renal injury by suppressing dyslipidemia via inhibition of ROS.
    Weihong C; Bin C; Jianfeng Y
    Biochem Biophys Res Commun; 2019 Jan; 509(1):40-47. PubMed ID: 30580996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the activation of heme oxygenase-1 on hormonal and metabolic changes in rats fed a high-fat diet.
    Szkudelski T; Dłużewicz K; Sadoch J; Szkudelska K
    Biomed Pharmacother; 2017 Mar; 87():375-380. PubMed ID: 28068626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of ATP-binding cassette transporter A1 (ABCA1) as a possible mechanism for the protective effect of cilostazol against hepatic steatosis.
    Jeon BH; Lee YH; Yun MR; Kim SH; Lee BW; Kang ES; Lee HC; Cha BS
    Metabolism; 2015 Nov; 64(11):1444-53. PubMed ID: 26362727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Protective Effects of Low Molecular Weight of Inonotus obliquus Polysaccharide (LIOP) on HFD/STZ-Induced Nephropathy in Mice.
    Chou YJ; Kan WC; Chang CM; Peng YJ; Wang HY; Yu WC; Cheng YH; Jhang YR; Liu HW; Chuu JJ
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of thymol on high fat diet induced diabetic nephropathy in C57BL/6J mice.
    Saravanan S; Pari L
    Chem Biol Interact; 2016 Feb; 245():1-11. PubMed ID: 26680107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative correlation of urinary miR-199a-3p level with ameliorating effects of sarpogrelate and cilostazol in hypertensive diabetic nephropathy.
    Kim SK; Kim G; Choi BH; Ryu D; Ku SK; Kwak MK
    Biochem Pharmacol; 2021 Feb; 184():114391. PubMed ID: 33359069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.